ArticleSignal transduction and targeted therapy2025

Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research.

Hai-Bo Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.